DNAPrint to Identify Genetic Markers for NYU Transplant Center | GenomeWeb

 

NEW YORK, Dec. 3 – DNAPrint Genomics of Sarasota, Fla., said Monday that it had entered an agreement with the New York University School of Medicine to identify genetic markers that can help determine how recipients of kidney transplants will respond to certain drugs. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.